RNU6-988P

Across TCGA pan-cancer cohorts, RNU6-988P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU6-988P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RNU6-988P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU6-988P is over-expressed in tumor, although a few such as KIRP and KICH show the opposite, repressed pattern.

KIRP, UCEC, and KICH are the cancer types where RNU6-988P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-988P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Female	All	−0.175	.025	3	view →
UCEC	All	IV	+1.004	.022	2	view →
KICH	Male	II,III,IV	−0.339	.024	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RNU6-988P–KIRP

Open the KIRP breakdown →